These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6106647)

  • 1. Increased insulin resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained by obesity.
    Nagulesparan M; Savage PJ; Mott DM; Johnson GC; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1980 Oct; 51(4):739-43. PubMed ID: 6106647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance.
    Lillioja S; Mott DM; Zawadzki JK; Young AA; Abbott WG; Bogardus C
    J Clin Endocrinol Metab; 1986 May; 62(5):922-7. PubMed ID: 3514652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
    Evans DJ; Murray R; Kissebah AH
    J Clin Invest; 1984 Oct; 74(4):1515-25. PubMed ID: 6148358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of postprandial insulin and glucose to glucose disposal in normal and insulin-resistant obese subjects.
    Klauser R; Prager R; Schernthaner G; Olefsky JM
    J Clin Endocrinol Metab; 1991 Oct; 73(4):758-64. PubMed ID: 1890150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women.
    McLaughlin T; Abbasi F; Carantoni M; Schaaf P; Reaven G
    J Clin Endocrinol Metab; 1999 Feb; 84(2):578-81. PubMed ID: 10022419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.
    Maheux P; Jeppesen J; Sheu WH; Hollenbeck CB; Clinkingbeard C; Greenfield MS; Chen YD; Reaven GM
    Hypertension; 1994 Dec; 24(6):695-8. PubMed ID: 7995625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians.
    Bogardus C; Lillioja S; Mott D; Reaven GR; Kashiwagi A; Foley JE
    J Clin Invest; 1984 Mar; 73(3):800-5. PubMed ID: 6368588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance.
    Frittitta L; Baratta R; Spampinato D; Di Paola R; Pizzuti A; Vigneri R; Trischitta V
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5888-91. PubMed ID: 11739459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of impaired glucose tolerance in the Pima Indians.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    N Engl J Med; 1988 Dec; 319(23):1500-6. PubMed ID: 3054559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies.
    Scheen AJ; Paquot N; Letiexhe MR; Paolisso G; Castillo MJ; Lefèbvre PJ
    Int J Obes Relat Metab Disord; 1995 Sep; 19 Suppl 3():S14-20. PubMed ID: 8581072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
    Brun JF; Aloulou I; Varlet-Marie E
    Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
    Zancanaro C; Cigolini M; Bonora E; Moghetti P; Cacciatori V; Querena M; Muggeo M
    Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an association of high blood pressure and hyperinsulinemia in obese man.
    Manicardi V; Camellini L; Bellodi G; Coscelli C; Ferrannini E
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1302-4. PubMed ID: 3517032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose effectiveness, peripheral and hepatic insulin sensitivity, in obese and lean prepubertal children.
    Hoffman RP; Armstrong PT
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):521-5. PubMed ID: 8782727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.
    Dandona P; Aljada A; Ghanim H; Mohanty P; Tripathy C; Hofmeyer D; Chaudhuri A
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5043-7. PubMed ID: 15472203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.